美国药监局对兰蔻产品发出警告

 

Regulators warned L'Oreal, the world's biggest cosmetics¹（化妆品） group, to stop advertising² skincare products using language that makes them sound like drugs.

 

The U.S. Food and Drug Administration said Lancome USA, a L'Oreal unit, claimed some of its skin creams could "boost the activity of genes³" or "stimulate⁴ cell regeneration" to reduce signs of aging.

 

Any product that is intended to affect the structure or function of the human body is classified as a drug, the FDA said, according to a warning letter posted on its website on Tuesday.

 

Companies are not allowed to sell drugs in the United States without submitting an application to the FDA proving their products are safe and effective and then winning FDA approval.

 

L'Oreal, a French company, was not immediately available for comment.

 

Some of the products mentioned in the letter, dated September 7, include Genifique Repair Youth Activating⁵ Night Cream and Absolue Eye Precious Cells Advanced Regenerating⁶ and Reconstructing Eye Cream.

 

On its website, Lancome describes the Genifique Repair cream, which costs $98 for a 1.7-ounce container, as "our first night care that boosts the activity of genes." The company cites an in-vitro test on genes to back up the claim.

 

The FDA said failure to fix the advertising claims could lead to enforcement actions, such as seizure⁷ of the products and injunctions（禁令，警告） against their manufacturers and distributors.

分享到：